Skip to content

Clinical trial to compare the cognitive improvement effects of electroacupuncture and computerized cognitive rehabilitation for mild cognitive impairment

A randomized, prospective single center clinical trial to compare the cognitive improvement effects of electroacupuncture and computerized cognitive rehabilitation for mild cognitive impairment

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0008861
Enrollment
64
Registered
2023-10-11
Start date
2023-10-05
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : - Computerized cognitive rehabilitation(CCR) group: Computerized cognitive rehabilitation (Rehacom) software treatment tasks are performed for 30 minutes once daily, twice a week for

Sponsors

Dongshin University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. an elderly aged between 55 and 85 years 2. impaired memory lasting for at least 3 months meeting the diagnostic criteria for MCI 3. Global Deterioration scale score of 2 or 3 4. Korean version of Mini-Mental State Examination(K-MMSE) score of 20–23 5. Korean version of Montreal Cognitive Assessment scale (MoCA-K) score of 0-22 6. Geriatric Depression Scale (GDS) score of 0-18 7. at least six years of education or adequate Korean language proficiency for reliable study assessments 8. voluntary provision of informed consent.

Exclusion criteria

Exclusion criteria: 1. Diagnosis of vascular dementia according to the NINDS-AIREN criteria or diagnosis of AD according to the NINCDS-ADRDA criteria 2. a history of structural brain lesions that could cause cognitive decline, such as congenital mental retardation, stroke, traumatic brain injury, or intracranial space-occupying lesions 3. presence of a serious illness (e.g., Huntington disease, Parkinson's disease, cancer, central nervous system, liver, cardiovascular, and kidney diseases, and multiple sclerosis) 4. a history of brain diseases confirmed on brain magnetic resonance imaging or computed tomography within 12 months 5. history of treatment for drug or alcohol dependency or mental illness (schizophrenia, serious anxiety, or depression) within 6 months prior to screening 6.current treatment for MCI, such as Korean medicine treatment, medication, or cognitive training within 4 weeks before screening 7. difficulties in undergoing outcome measurement due to visual and hearing impairments 8. unfitness for electroacupuncture (e.g., blood-clotting abnormalities such as hemophilia, scalp infection, and presence of a pacemaker) 9. pregnancy or breastfeeding 10. A people who is participating in other trials or has participated in other trials within 8 weeks prior to screening

Design outcomes

Primary

MeasureTime frame
Korean version of the Montreal Cognitive Assessment(MoCA-K)

Secondary

MeasureTime frame
Alzheimer's Disease Asessment Scale-Korean version-cognitive subscale-3(ADAS-K-cog-3);Geriatric Depression scale(GDS);European Quality of Life Five Dimension. Five Level Scale(EQ-5D-5L)

Countries

Korea, Republic of

Contacts

Public ContactKim Jae-Hong

Dongshin University

nahonga@hanmail.net+82-62-350-7209

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 6, 2026